Showing results (191-200 of 311) with videos related to

Sort By:
Pageof 32
American Journal of Clinical Oncology|February 24, 2001
Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma: a Gynecologic Oncology Group StudyG F Fleming, B J Roth, S D Baker, et al.
Cancer Treatment Reports|January 1, 1979
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474)D F Chiuten, J M Bennett, R H Creech, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Comparative N-glucuronidation kinetics of ketotifen and amitriptyline by expressed human UDP-glucuronosyltransferases and liver microsomesU Breyer-Pfaff, U Mey, M D Green, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1992
Studies on tertiary amine UDP-glucuronosyltransferases from human and rabbit hepatic microsomesP B Styczynski, M D Green, B Coffman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adductsI Gill, F M Muggia, P M Terheggen, et al.
Cancer Clinical Trials|January 1, 1981
Animal toxicology for early clinical trials with anticancer agentsM Rozencweig, D D Von Hoff, M J Staquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group studyF M Muggia, P S Braly, M F Brady, et al.
The Biochemical Journal|September 1, 1985
Strain differences in purified rat hepatic 3 alpha-hydroxysteroid UDP-glucuronosyltransferaseM D Green, C N Falany, R B Kirkpatrick, et al.
Pageof 32